FDA Inspection
Shandong Anxin Pharmaceutical Co., Ltd.Shandong Anxin Pharmaceutical Co., Ltd. – FDA Inspection, Jul 16, 2026
Record Details
This FDA Inspection record concerns Shandong Anxin Pharmaceutical Co., Ltd., with an inspection on July 16, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 2f2e8d70-9297-4dc6-ad52-72f41affc3fa
Inspection Facts
- Inspection number
- 1332590
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Shandong Anxin Pharmaceutical Co., Ltd.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2024 | Not classified | Office of Inspections and Investigations | |
| September 18, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 1, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2017 | Not classified | Office of Inspections and Investigations | |
| June 2, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shandong Anxin Pharmaceutical Co., Ltd.
- FDA Inspection 1249598 - 2024-08-21
- FDA Inspection 1157432 - 2019-09-18
- FDA Inspection 1028356 - 2017-09-01
- FDA Inspection 1019841 - 2017-06-10
- FDA Inspection 929464 - 2015-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.